Latest Breaking News On - Psychoactive trials group at king college - Page 1 : vimarsana.com

Initial data from phase 2 safety profile for psilocybin in the treatment of PTSD indicates the treatment is well-tolerated.

New yorkUnited statesUnited kingdomCity ofJames ruckerGuy goodwinInstitute of psychiatryPsychoactive trials group at king collegeIcahn school of medicine at mount sinaiKing collegeIcahn schoolMount sinaiNew york citySunstone therapiesCompass pathwaysPsychoactive trials group